Tag - IRWD

Executive Moves

Ironwood appoints Tammi Gaskins as CEO

Ironwood Pharmaceuticals (NASDAQ: IRWD) has announced the appointment of chief commercial officer Tammi Gaskins as CEO and a member of the board of directors, effective January 1, 2027. Current CEO Tom McCourt will...

October 16, 2026

Developments

Ironwood reports updates on apraglutide following FDA interaction

Ironwood Pharmaceuticals (NASDAQ:IRWD) announced that a confirmatory Phase 3 trial evaluating apraglutide in short bowel syndrome with intestinal failure (SBS-IF) and dependence on parenteral support, is a requirement...

April 14, 2025

Tag - IRWD

Ironwood appoints Tammi Gaskins as CEO

Ironwood reports updates on apraglutide following FDA interaction

Subscribe